Page 1028 - Clinical Immunology_ Principles and Practice ( PDFDrive )

CHaPter 73 Sarcoidosis 991

9. Dumas O, Abramovitz L, Wiley AS, et al. Epidemiology of sarcoidosis in a 31. Christophi GP, Caza T, Curtiss C, et al. Gene expression profiles in
prospective cohort study of U.S. women. Ann Am Thorac Soc granuloma tissue reveal novel diagnostic markers in sarcoidosis.
2016;13:67–71. Exp Mol Pathol 2014;96:393–9.
10. Swigris JJ, Olson AL, Huie TJ, et al. Sarcoidosis-related mortality in the 32. Ramstein J, Broos CE, Simpson LJ, et al. Interferon-gamma-producing
United States from 1988 to 2007. Am J Respir Crit Care Med Th17.1 cells are increased in sarcoidosis and more prevalent than Th1
2011;183:1524–30. cells. Am J Respir Crit Care Med 2016;193:1281–91.
11. Rybicki BA, Iannuzzi MC, Frederick MM, et al. Familial aggregation of 33. Kaiser Y, Lepzien R, Kullberg S, et al. Expanded lung
sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS). T-bet+RORgammaT+ CD4+ T-cells in sarcoidosis patients with a
Am J Respir Crit Care Med 2001;164:2085–91. favourable disease phenotype. Eur Respir J 2016;48:484–94.
12. Fischer A, Grunewald J, Spagnolo P, et al. Genetics of sarcoidosis. Semin 34. Taflin C, Miyara M, Nochy D, et al. FoxP3+ regulatory T cells suppress
Respir Crit Care Med 2014;35:296–306. early stages of granuloma formation but have little impact on sarcoidosis
13. Medica I, Kastrin A, Maver A, et al. Role of genetic polymorphisms in lesions. Am J Pathol 2009;174:497–508.
ACE and TNF-alpha gene in sarcoidosis: a meta-analysis. J Hum Genet 35. Broos CE, van Nimwegen M, Kleinjan A, et al. Impaired survival of
2007;52:836–47. regulatory T cells in pulmonary sarcoidosis. Respir Res 2015;16:108.
14. Bello GA, Adrianto I, Dumancas GG, et al. Role of NOD2 pathway 36. Prasse A, Zissel G, Lutzen N, et al. Inhaled vasoactive intestinal peptide
genes in sarcoidosis cases with clinical characteristics of Blau syndrome. exerts immunoregulatory effects in sarcoidosis. Am J Respir Crit Care
Am J Respir Crit Care Med 2015;192:1133–5. Med 2010;182:540–8.
15. Rybicki BA, Walewski JL, Maliarik MJ, et al. The BTNL2 gene and 37. Gabrilovich MI, Walrath J, van Lunteren J, et al. Disordered Toll-like
sarcoidosis susceptibility in African Americans and Whites. Am J Hum receptor 2 responses in the pathogenesis of pulmonary sarcoidosis.
Genet 2005;77:491–9. Clin Exp Immunol 2013;173:512–22.
16. Morais A, Lima B, Peixoto MJ, et al. BTNL2 gene polymorphism 38. Veltkamp M, van Moorsel CH, Rijkers GT, et al. Genetic variation in the
associations with susceptibility and phenotype expression in sarcoidosis. Toll-like receptor gene cluster (TLR10-TLR1-TLR6) influences disease
Respir Med 2012;106:1771–7. course in sarcoidosis. Tissue Antigens 2012;79:25–32.
17. Wennerstrom A, Pietinalho A, Lasota J, et al. Major histocompatibility 39. Preusse C, Goebel HH, Pehl D, et al. Th2-M2 immunity in lesions of
complex class II and BTNL2 associations in sarcoidosis. Eur Respir J muscular sarcoidosis and macrophagic myofasciitis. Neuropathol Appl
2013;42:550–3. Neurobiol 2015;41:952–63.
18. Mirsaeidi M, Gidfar S, Vu A, et al. Annexins family: insights into their 40. Boot RG, Hollak CE, Verhoek M, et al. Plasma chitotriosidase and CCL18
functions and potential role in pathogenesis of sarcoidosis. J Transl Med as surrogate markers for granulomatous macrophages in sarcoidosis.
2016;14:89. Clin Chim Acta 2010;411:31–6.
19. Fischer A, Ellinghaus D, Nutsua M, et al. Identification of 41. Prasse A, Pechkovsky DV, Toews GB, et al. A vicious circle of alveolar
immune-relevant factors conferring sarcoidosis genetic risk. Am J Respir macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18.
Crit Care Med 2015;192:727–36. Am J Respir Crit Care Med 2006;173:781–92.
20. Crowley LE, Herbert R, Moline JM, et al. Sarcoid like” granulomatous 42. Zhang Y, Chen X, Hu Y, et al. Preliminary characterizations of a serum
pulmonary disease in World Trade Center disaster responders. Am J Ind biomarker for sarcoidosis by comparative proteomic approach with
Med 2011;54:175–84. tandem-mass spectrometry in ethnic Han Chinese patients. Respir Res
21. Loupasakis K, Berman J, Jaber N, et al. Refractory sarcoid arthritis in 2013;14:18.
World Trade Center-exposed New York City firefighters: a case series. 43. Sileo C, Epaud R, Mahloul M, et al. Sarcoidosis in children: HRCT
J Clin Rheumatol 2015;21:19–23. findings and correlation with pulmonary function tests. Pediatr Pulmonol
22. Gupta D, Agarwal R, Aggarwal AN, et al. Molecular evidence for the role 2014;49:1223–33.
of mycobacteria in sarcoidosis: a meta-analysis. Eur Respir J 44. Maimon N, Salz L, Shershevsky Y, et al. Sarcoidosis-associated pulmonary
2007;30:508–16. hypertension in patients with near-normal lung function. Int J Tuberc
23. Teirstein AS. Kveim antigen: what does it tell us about causation of Lung Dis 2013;17:406–11.
sarcoidosis? Semin Respir Infect 1998;13:206–11. 45. Birnie DH, Sauer WH, Bogun F, et al. HRS expert consensus statement
24. Chen ES, Wahlstrom J, Song Z, et al. T cell responses to mycobacterial on the diagnosis and management of arrhythmias associated with cardiac
catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis. sarcoidosis. Heart Rhythm 2014;11:1305–23.
J Immunol 2008;181:8784–96. 46. Mehta D, Lubitz SA, Frankel Z, et al. Cardiac involvement in patients
25. Drake WP, Dhason MS, Nadaf M, et al. Cellular recognition of with sarcoidosis: diagnostic and prognostic value of outpatient testing.
Mycobacterium tuberculosis ESAT-6 and KatG peptides in systemic Chest 2008;133:1426–35.
sarcoidosis. Infect Immun 2007;75:527–30. 47. Bradley B, Branley HM, Egan JJ, et al. Interstitial lung disease guideline:
26. Eishi Y, Suga M, Ishige I, et al. Quantitative analysis of mycobacterial the British Thoracic Society in collaboration with the Thoracic Society of
and propionibacterial DNA in lymph nodes of Japanese and Australia and New Zealand and the Irish Thoracic Society. Thorax
European patients with sarcoidosis. J Clin Microbiol 2002;40: 2008;63(Suppl. 5):v1–58.
198–204. 48. Baughman RP, Lower EE. Treatment of sarcoidosis. Clin Rev Allergy
27. Kobak S, Yilmaz H, Sever F, et al. The prevalence of antinuclear Immunol 2015;49:79–92.
antibodies in patients with sarcoidosis. Autoimmune Dis 49. Barnett CF, Bonura EJ, Nathan SD, et al. Treatment of
2014;2014:351852. sarcoidosis-associated pulmonary hypertension. A two-center experience.
28. Rossi G, Cavazza A, Colby TV. Pathology of sarcoidosis. Clin Rev Allergy Chest 2009;135:1455–61.
Immunol 2015;49:36–44. 50. Bonham CA, Oldham JM, Gomberg-Maitland M, et al. Prostacyclin and
29. Zissel G, Prasse A, Muller-Quernheim J. Immunologic response of oral vasodilator therapy in sarcoidosis-associated pulmonary
sarcoidosis. Semin Respir Crit Care Med 2010;31:390–403. hypertension: a retrospective case series. Chest 2015;148:1055–62.
30. Koth LL, Solberg OD, Peng JC, et al. Sarcoidosis blood transcriptome 51. Chen ES, Song Z, Willett MH, et al. Serum amyloid A regulates
reflects lung inflammation and overlaps with tuberculosis. Am J Respir granulomatous inflammation in sarcoidosis through Toll-like receptor-2.
Crit Care Med 2011;184:1153–63. Am J Respir Crit Care Med 2010;181:360–73.